Akero Therapeutics (AKRO) News Today $48.37 -0.48 (-0.98%) Closing price 08/1/2025 04:00 PM EasternExtended Trading$48.32 -0.05 (-0.10%) As of 08/1/2025 05:46 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock AKRO Latest News All Sources Trusted Sources MarketBeat Benzinga Bloomberg GlobeNewswire GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent August 2025 July 2025 June 2025 May 2025 April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 Time Period TD Asset Management Inc Has $8.45 Million Stock Position in Akero Therapeutics, Inc. (NASDAQ:AKRO)August 1 at 3:51 AM | marketbeat.comAkero Therapeutics (AKRO) Expected to Announce Earnings on FridayAugust 1 at 2:14 AM | marketbeat.com33,611 Shares in Akero Therapeutics, Inc. (NASDAQ:AKRO) Bought by Picton Mahoney Asset ManagementJuly 30 at 4:49 AM | marketbeat.comSkandinaviska Enskilda Banken AB publ Purchases Shares of 7,676 Akero Therapeutics, Inc. (NASDAQ:AKRO)July 30 at 4:20 AM | marketbeat.comVictory Capital Management Inc. Buys 27,881 Shares of Akero Therapeutics, Inc. (NASDAQ:AKRO)July 30 at 3:53 AM | marketbeat.comTeachers Retirement System of The State of Kentucky Sells 9,256 Shares of Akero Therapeutics, Inc. (NASDAQ:AKRO)July 26, 2025 | marketbeat.comAstraZeneca’s Anselamimab Misses Primary Endpoint in Amyloidosis Trials, Shows Promise in SubgroupJuly 26, 2025 | msn.comReadystate Asset Management LP Invests $4.07 Million in Akero Therapeutics, Inc. (NASDAQ:AKRO)July 23, 2025 | marketbeat.comJennison Associates LLC Takes Position in Akero Therapeutics, Inc. (NASDAQ:AKRO)July 23, 2025 | marketbeat.comKennondale Capital Management LLC Has $571,000 Stock Holdings in Akero Therapeutics, Inc. (NASDAQ:AKRO)July 22, 2025 | marketbeat.comBank of New York Mellon Corp Purchases 12,235 Shares of Akero Therapeutics, Inc. (NASDAQ:AKRO)July 22, 2025 | marketbeat.comEdgestream Partners L.P. Buys Shares of 6,947 Akero Therapeutics, Inc. (NASDAQ:AKRO)July 21, 2025 | marketbeat.comXponance Inc. Buys Shares of 5,565 Akero Therapeutics, Inc. (NASDAQ:AKRO)July 20, 2025 | marketbeat.comAkero Therapeutics shares plunge on liver disease treatment’s mixed ...July 19, 2025 | marketwatch.comAkero Therapeutics, Inc. (NASDAQ:AKRO) Insider Catriona Yale Sells 10,000 SharesJuly 19, 2025 | marketbeat.comCorcept Seeks FDA Approval for Relacorilant in Ovarian CancerJuly 15, 2025 | msn.comAkero Therapeutics, Inc. (NASDAQ:AKRO) Given Consensus Recommendation of "Buy" by BrokeragesJuly 14, 2025 | marketbeat.comPrincipal Financial Group Inc. Purchases New Position in Akero Therapeutics, Inc. (NASDAQ:AKRO)July 14, 2025 | marketbeat.comAkero Therapeutics, Inc. (NASDAQ:AKRO) Position Reduced by Emerald Advisers LLCJuly 13, 2025 | marketbeat.comEmerald Mutual Fund Advisers Trust Cuts Position in Akero Therapeutics, Inc. (NASDAQ:AKRO)July 12, 2025 | marketbeat.comAndrew Cheng Sells 30,000 Shares of Akero Therapeutics, Inc. (NASDAQ:AKRO) StockJuly 11, 2025 | marketbeat.comInsider Selling: Akero Therapeutics, Inc. (NASDAQ:AKRO) Insider Sells 12,500 Shares of StockJuly 9, 2025 | marketbeat.comInsider Selling: Akero Therapeutics, Inc. (NASDAQ:AKRO) VP Sells 2,000 Shares of StockJuly 3, 2025 | marketbeat.comAKRO - Akero Therapeutics Inc Valuation - MorningstarJuly 3, 2025 | morningstar.comMOppenheimer & Co. Inc. Takes Position in Akero Therapeutics, Inc. (NASDAQ:AKRO)July 3, 2025 | marketbeat.comAkero Therapeutics (NASDAQ:AKRO) Stock Price Down 4.8% - Should You Sell?June 30, 2025 | marketbeat.comInsider Selling: Akero Therapeutics, Inc. (NASDAQ:AKRO) CTO Sells 848 Shares of StockJune 21, 2025 | insidertrades.comAkero Therapeutics, Inc. (NASDAQ:AKRO) CTO Sells $46,504.32 in StockJune 20, 2025 | marketbeat.comAkero Therapeutics, Inc. (NASDAQ:AKRO) VP Patrick Lamy Sells 875 SharesJune 20, 2025 | marketbeat.comAkero Therapeutics, Inc. (NASDAQ:AKRO) Insider Timothy Rolph Sells 1,129 SharesJune 20, 2025 | marketbeat.comAkero Therapeutics, Inc. (NASDAQ:AKRO) COO Jonathan Young Sells 1,453 SharesJune 20, 2025 | marketbeat.comAkero Therapeutics, Inc. (NASDAQ:AKRO) Insider Sells $89,553.72 in StockJune 20, 2025 | marketbeat.comWilliam Richard White Sells 1,634 Shares of Akero Therapeutics, Inc. (NASDAQ:AKRO) StockJune 20, 2025 | marketbeat.comAkero Therapeutics, Inc. (NASDAQ:AKRO) CEO Andrew Cheng Sells 6,620 SharesJune 20, 2025 | marketbeat.comPatrick Lamy Sells 2,000 Shares of Akero Therapeutics, Inc. (NASDAQ:AKRO) StockJune 20, 2025 | marketbeat.comGAMMA Investing LLC Grows Stock Position in Akero Therapeutics, Inc. (NASDAQ:AKRO)June 20, 2025 | marketbeat.comAkero Therapeutics, Inc. (NASDAQ:AKRO) Given Average Rating of "Buy" by AnalystsJune 19, 2025 | marketbeat.comAkero Therapeutics (NASDAQ:AKRO) Trading Down 3.3% - Here's What HappenedJune 16, 2025 | marketbeat.comRhumbline Advisers Purchases 5,001 Shares of Akero Therapeutics, Inc. (NASDAQ:AKRO)June 14, 2025 | marketbeat.comJefferies Names Akero Therapeutics, Scholar Rock As Biotech Companies With Takeover Potential, But Retail Isn’t PleasedJune 13, 2025 | msn.comPatrick Lamy Sells 919 Shares of Akero Therapeutics, Inc. (NASDAQ:AKRO) StockJune 13, 2025 | insidertrades.comInsider Selling: Akero Therapeutics, Inc. (NASDAQ:AKRO) VP Sells 919 Shares of StockJune 12, 2025 | marketbeat.comAkero Therapeutics, Inc. (NASDAQ:AKRO) Insider Timothy Rolph Sells 2,358 SharesJune 12, 2025 | marketbeat.comInsider Selling: Akero Therapeutics, Inc. (NASDAQ:AKRO) COO Sells 2,493 Shares of StockJune 12, 2025 | marketbeat.comAkero Therapeutics, Inc. (NASDAQ:AKRO) Insider Catriona Yale Sells 2,803 SharesJune 12, 2025 | marketbeat.comWilliam Richard White Sells 2,804 Shares of Akero Therapeutics, Inc. (NASDAQ:AKRO) StockJune 12, 2025 | marketbeat.comAndrew Cheng Sells 37,837 Shares of Akero Therapeutics, Inc. (NASDAQ:AKRO) StockJune 12, 2025 | marketbeat.comAkero Therapeutics, Inc. (NASDAQ:AKRO) Stake Raised by SG Americas Securities LLCJune 10, 2025 | marketbeat.comMillennium Management LLC Sells 57,892 Shares of Akero Therapeutics, Inc. (NASDAQ:AKRO)June 10, 2025 | marketbeat.comAkero Therapeutics, Inc. (NASDAQ:AKRO) Insider Timothy Rolph Sells 12,500 SharesJune 9, 2025 | marketbeat.com Get Akero Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for AKRO and its competitors with MarketBeat's FREE daily newsletter. Email Address AKRO Media Mentions By Week AKRO Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. AKRO News Sentiment▼1.290.45▲Average Medical News Sentiment AKRO News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. AKRO Articles This Week▼57▲AKRO Articles Average Week Get Akero Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for AKRO and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies Genmab A/S News Moderna News Dr. Reddy's Laboratories News QIAGEN News Viatris News Ascendis Pharma A/S News BridgeBio Pharma News Verona Pharma PLC American Depositary Share News Blueprint Medicines News Legend Biotech News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:AKRO) was last updated on 8/2/2025 by MarketBeat.com Staff From Our PartnersI warned you about Nvidia… now look what’s happeningNvidia just got Trump’s greenlight to sell high-powered AI chips to China — and their stock surged 5% before t...Timothy Sykes | SponsoredTrump set to Boost Social Security Checks by 400%?If you're collecting or planning to collect social security... You should see this presentation about Presi...InvestorPlace | SponsoredNew Federal Land Rush About to Start?A $100 Trillion Wealth Shift Is Already Underway Lithium. Oil. Gold. Trillions in U.S. resources are being ...Stansberry Research | Sponsored$100 Trillion “AI Metal” Found in American Ghost TownJeff Brown recently traveled to a ghost town in the middle of an American desert… To investigate what could...Brownstone Research | SponsoredHIDDEN IN THE BOOK OF GENESIS…“This land I will give to you…” — a 4,000-year-old line from Genesis may hold the key to unlocking a $150 tril...Paradigm Press | SponsoredHe Called Nvidia at $1.10. Now, He Says THIS Stock Will…The original Magnificent Seven returned 16,894%—turning $7K into $1.18 million. Now, the man who called Nvi...The Oxford Club | SponsoredDigital Dollar Alert: Protect Your Wealth Before It’s Too Late134 countries are developing Central Bank Digital Currencies — and the U.S. is quietly testing one. Experts...American Alternative | SponsoredAlien rocks potentially worth trillions…It might look like just a weird rock—but it’s tied to a discovery 60 Minutes says could be worth up to $16 tri...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Akero Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Akero Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free AKRO Stock Alerts